SiriusXT
Dublin
About SiriusXT
SiriusXT has developed and manufactures a soft x-ray microscope (the SXT system), which is marketed primarily to researchers working in disease research and drug discovery. The core technology, underpinning the SiriusXT microscope is a vacuum-based laser-produced plasma (LPP) soft x-ray light source. Soft x-ray tomography is essentially a CT scan of the cell, and is critical to life scientists looking to image the 3D internal structure of an entire cell in its native fully hydrated state. The SXT system is used by disease researchers, pharmaceutical companies, bio-technologists and clinicians to aid the understanding of disease pathways, protein-drug interactions and bio-engineering processes. SiriusXT provides the first high-throughput, bench-top, SXT system in the world, capable of producing high resolution, full cell 3D tomographs in minutes.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $17.4M
- Last round: Grant (Oct 2020)
- Website: siriusxt.com
- Phone: +35319056340
Industries & Categories
Biotechnology, Hospital, Manufacturing, Medical, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/siriusxt-30953 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.